DrugDashboards

Calcium Acetate

Calcium Acetate · CALCIUM ACETATE 667 mg/1 · Capsule · PLD Acquisitions LLC DBA Avma Pharma Solutions

NDC 63548-6990-00 · 34935227 DRUM in 1 DRUM / 34935227 CAPSULE in 1 DRUM · BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (bulk ingredient for human prescription compounding) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 69097-0862-83) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$0.2701per unit
middle half $0.2148–$0.4149 · 1,989 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.2701
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
36%of plans cover it
tier 3 · prior auth 71% · step therapy 0% · qty limit 15%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 1 quarter since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for calcium acetate (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $71.66 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Xywav and Xyrem

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Calcium Acetate (Capsule)

LabelerStrengthFirst seenLast seen
Amneal Pharmaceuticals of New York LLCCALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
AvKARECALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
AvPAKCALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCCALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLC.CALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Cipla USA Inc.,CALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Exelan Pharmaceuticals, Inc.CALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.CALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.CALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsCALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
NCS HealthCare of KY, LLC dba Vangard LabsCALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Nivagen Pharmaceuticals, Inc.CALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
PD-Rx Pharmaceuticals, Inc.CALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
PLD Acquisitions LLC DBA Avma Pharma SolutionsCALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPCALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.CALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.CALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Square Pharmaceuticals LimitedCALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCCALCIUM ACETATE 667 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingCALCIUM ACETATE 667 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Calcium Acetate — NDC 63548-6990-00," retrieved September 3, 2026, https://drugdashboards.com/drug/63548699000.

Free to cite with attribution — see how the data is put together.